Drug intelligence / Profile preview

thiocolchicoside + ibuprofen

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral
01

Overview

**Thiocolchicoside + ibuprofen** is a fixed-dose combination drug containing the muscle relaxant thiocolchicoside and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen. Thiocolchicoside is a synthetic sulfur-containing derivative of a natural colchicoside, acting as a centrally acting muscle relaxant. Ibuprofen is a widely used NSAID that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and thereby alleviating pain and inflammation. The combination is primarily indicated as an adjunctive treatment for **acute musculoskeletal conditions**, such as painful contractures and acute low back pain, where both muscle spasm and pain are present. Clinical studies show significant efficacy in improving pain, functional disability, and muscle contracture compared to monotherapy with either agent. The combination may be formulated as tablets, capsules, or granules for **oral administration**[1][5].

02

Targets

GABRR (GABA-A receptor subunit rho)GLRA1 (Glycine receptor subunit Alpha-1)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on thiocolchicoside + ibuprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thiocolchicoside + ibuprofen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call